These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21793038)

  • 41. Multitarget Therapeutic Effect of Fasudil in APP/PS1transgenic Mice.
    Yu JZ; Li YH; Liu CY; Wang Q; Gu QF; Wang HQ; Zhang GX; Xiao BG; Ma CG
    CNS Neurol Disord Drug Targets; 2017; 16(2):199-209. PubMed ID: 27401064
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20-APP transgenic and wild-type mice.
    Tapia-Rojas C; Inestrosa NC
    J Neurochem; 2018 Feb; 144(4):443-465. PubMed ID: 29240990
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protocatechuic acid improves cognitive deficits and attenuates amyloid deposits, inflammatory response in aged AβPP/PS1 double transgenic mice.
    Song Y; Cui T; Xie N; Zhang X; Qian Z; Liu J
    Int Immunopharmacol; 2014 May; 20(1):276-81. PubMed ID: 24667368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deferoxamine enhances alternative activation of microglia and inhibits amyloid beta deposits in APP/PS1 mice.
    Zhang Y; He ML
    Brain Res; 2017 Dec; 1677():86-92. PubMed ID: 28963052
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quetiapine modulates conditioned anxiety and alternation behavior in Alzheimer's transgenic mice.
    Tempier A; He J; Zhu S; Zhang R; Kong L; Tan Q; Luo H; Kong J; Li XM
    Curr Alzheimer Res; 2013 Feb; 10(2):199-206. PubMed ID: 22950914
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
    Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Benzo(a)pyrene exposure induced neuronal loss, plaque deposition, and cognitive decline in APP/PS1 mice.
    Liu D; Zhao Y; Qi Y; Gao Y; Tu D; Wang Y; Gao HM; Zhou H
    J Neuroinflammation; 2020 Aug; 17(1):258. PubMed ID: 32867800
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The nootropic and neuroprotective proline-containing dipeptide noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's disease model.
    Ostrovskaya RU; Gruden MA; Bobkova NA; Sewell RD; Gudasheva TA; Samokhin AN; Seredinin SB; Noppe W; Sherstnev VV; Morozova-Roche LA
    J Psychopharmacol; 2007 Aug; 21(6):611-9. PubMed ID: 17092975
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Xanomeline derivative EUK1001 attenuates Alzheimer's disease pathology in a triple transgenic mouse model.
    Li Z; Jia K; Duan Y; Wang D; Zhou Z; Dong S
    Mol Med Rep; 2017 Nov; 16(5):7835-7840. PubMed ID: 28944835
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enriched endogenous n-3 polyunsaturated fatty acids alleviate cognitive and behavioral deficits in a mice model of Alzheimer's disease.
    Wu K; Gao X; Shi B; Chen S; Zhou X; Li Z; Gan Y; Cui L; Kang JX; Li W; Huang R
    Neuroscience; 2016 Oct; 333():345-55. PubMed ID: 27474225
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liquiritigenin attenuates the learning and memory deficits in an amyloid protein precursor transgenic mouse model and the underlying mechanisms.
    Liu RT; Tang JT; Zou LB; Fu JY; Lu QJ
    Eur J Pharmacol; 2011 Nov; 669(1-3):76-83. PubMed ID: 21872584
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
    J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice.
    Kurata T; Miyazaki K; Kozuki M; Panin VL; Morimoto N; Ohta Y; Nagai M; Ikeda Y; Matsuura T; Abe K
    Brain Res; 2011 Jan; 1371():161-70. PubMed ID: 21112317
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Beneficial effects of dietary EGCG and voluntary exercise on behavior in an Alzheimer's disease mouse model.
    Walker JM; Klakotskaia D; Ajit D; Weisman GA; Wood WG; Sun GY; Serfozo P; Simonyi A; Schachtman TR
    J Alzheimers Dis; 2015; 44(2):561-72. PubMed ID: 25318545
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice.
    Zhao G; Liu HL; Zhang H; Tong XJ
    Neuroscience; 2015 Jul; 298():357-66. PubMed ID: 25917310
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-Inflammatory Treatment with FTY720 Starting after Onset of Symptoms Reverses Synaptic Deficits in an AD Mouse Model.
    Kartalou GI; Salgueiro-Pereira AR; Endres T; Lesnikova A; Casarotto P; Pousinha P; Delanoe K; Edelmann E; Castrén E; Gottmann K; Marie H; Lessmann V
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255764
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gender difference in valproic acid-induced neuroprotective effects on APP/PS1 double transgenic mice modeling Alzheimer's disease.
    Long Z; Zeng Q; Wang K; Sharma A; He G
    Acta Biochim Biophys Sin (Shanghai); 2016 Oct; 48(10):930-938. PubMed ID: 27614317
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protective effect of potassium 2-(l-hydroxypentyl)-benzoate on hippocampal neurons, synapses and dystrophic axons in APP/PS1 mice.
    Huang L; Zhang Y; Peng Y; Zhao Z; Zhou Y; Wang X; Peng Y
    Psychopharmacology (Berl); 2019 Sep; 236(9):2761-2771. PubMed ID: 31165206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.
    Adegoke OO; Qiao F; Liu Y; Longley K; Feng S; Wang H
    J Alzheimers Dis; 2017; 59(2):575-590. PubMed ID: 28598849
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risperidone ameliorated Aβ
    Wu L; Feng X; Li T; Sun B; Khan MZ; He L
    Behav Brain Res; 2017 Mar; 322(Pt A):145-156. PubMed ID: 28093254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.